BE1003227A3 - Tripeptides utiles comme immunostimulants de meme que dans la prevention des metastases. - Google Patents

Tripeptides utiles comme immunostimulants de meme que dans la prevention des metastases. Download PDF

Info

Publication number
BE1003227A3
BE1003227A3 BE8800895A BE8800895A BE1003227A3 BE 1003227 A3 BE1003227 A3 BE 1003227A3 BE 8800895 A BE8800895 A BE 8800895A BE 8800895 A BE8800895 A BE 8800895A BE 1003227 A3 BE1003227 A3 BE 1003227A3
Authority
BE
Belgium
Prior art keywords
immunostimulants
metastases
prevention
well
tripeptides
Prior art date
Application number
BE8800895A
Other languages
English (en)
Inventor
Brunetti Brunetto
Prada Marco
Original Assignee
Ellem Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellem Ind Farmaceutica filed Critical Ellem Ind Farmaceutica
Application granted granted Critical
Publication of BE1003227A3 publication Critical patent/BE1003227A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des tripeptides de formule générale X-Gly-Y dans laquelle X = L-Arg ou D-Arg, et Y = L-Asp ou D-Asp. Ces tripeptides, possédant des propriétés antimétastatique et 05 immunostimulante, sont actifs non seulement après administration parentérale, mais également après traitement oral. L'invention concerne également un procédé de préparation de ces composés.
BE8800895A 1987-08-04 1988-08-02 Tripeptides utiles comme immunostimulants de meme que dans la prevention des metastases. BE1003227A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21575/87A IT1222437B (it) 1987-08-04 1987-08-04 Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione

Publications (1)

Publication Number Publication Date
BE1003227A3 true BE1003227A3 (fr) 1992-02-04

Family

ID=11183828

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800895A BE1003227A3 (fr) 1987-08-04 1988-08-02 Tripeptides utiles comme immunostimulants de meme que dans la prevention des metastases.

Country Status (13)

Country Link
US (1) US4929601A (fr)
JP (1) JPS6463593A (fr)
AT (1) ATA195788A (fr)
BE (1) BE1003227A3 (fr)
CH (1) CH678059A5 (fr)
DE (1) DE3826595C2 (fr)
FR (1) FR2621317B1 (fr)
GB (1) GB2207922B (fr)
GR (1) GR1000339B (fr)
IE (1) IE60870B1 (fr)
IT (1) IT1222437B (fr)
NL (1) NL8801932A (fr)
SE (1) SE8802790L (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156490A (en) * 1976-05-25 1979-05-29 Prot S.R.L. Method of hermetically sealing soft-drink bottles and like containers
AU639409B2 (en) * 1987-12-10 1993-07-29 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5827821A (en) 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
CA1324954C (fr) * 1988-03-10 1993-12-07 Erkki I. Ruoslahti Inhibition de la migration cellulaire au moyen de peptides synthetiques
US5236903A (en) * 1988-06-24 1993-08-17 Ichiro Azuma Polypeptide comprising repeated cell-adhesive core sequences
JP2625156B2 (ja) * 1988-06-24 1997-07-02 市郎 東 細胞接着活性コア配列の繰り返し構造からなるポリペプチド
IT1226552B (it) * 1988-07-29 1991-01-24 Ellem Ind Farmaceutica Peptidi immunostimolanti.
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5795868A (en) * 1989-06-16 1998-08-18 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5770564A (en) * 1989-06-16 1998-06-23 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
ATE155482T1 (de) * 1990-04-06 1997-08-15 Jolla Cancer Res Found Verfahren und verbindung zur behandlung von thrombose
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
AU9131091A (en) * 1990-11-07 1992-06-11 Scripps Research Institute, The Peptides that inhibit platelet binding of adhesion molecules
DK0578728T3 (da) * 1991-04-05 1999-04-12 Genentech Inc Inhibitorer for aggregering af blodplader, hvilke inhibitorer har høj specificitet for GP IIbIIIa
HUT63609A (en) * 1992-03-10 1993-09-28 Sandoz Ag Process for producing new derivatives and isosters of beta-amino acids and pharmaceutical compositions comprising such compounds
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
ES2280962T3 (es) * 2003-05-08 2007-09-16 Pentapharm Ag Tripeptidos y derivados de los mismos para aplicaciones cosmeticas para la estructura de la piel.
RU2301074C1 (ru) * 2006-05-30 2007-06-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, обладающий иммуногеропротекторным действием, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743590A (en) * 1978-07-31 1988-05-10 Debarbieri Augusto In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
US4508710A (en) * 1978-07-31 1985-04-02 Proter S.P.A. In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
FR2569111B1 (fr) * 1984-08-16 1987-04-17 Rhone Poulenc Sante Nouveaux medicaments contenant des tripeptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. EXP. MED., vol. 162, août 1985, pages 762-767, The Rockefeller University Press; S.D. WRIGHT et al.: "Fibronectin receptor of human macrophages recognizes the sequence Arg-Gly-Asp-Ser" *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 82, septembre 1985, pages 5766-5770; R. PYTELA et al.: "A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin" *

Also Published As

Publication number Publication date
NL8801932A (nl) 1989-03-01
DE3826595C2 (de) 1994-02-17
IT8721575A0 (it) 1987-08-04
GB8818447D0 (en) 1988-09-07
GR1000339B (el) 1992-06-25
SE8802790L (sv) 1989-02-05
GR880100509A (en) 1989-05-25
DE3826595A1 (de) 1989-02-16
JPS6463593A (en) 1989-03-09
US4929601A (en) 1990-05-29
SE8802790D0 (sv) 1988-08-02
IT1222437B (it) 1990-09-05
FR2621317B1 (fr) 1994-06-17
CH678059A5 (fr) 1991-07-31
ATA195788A (de) 1996-05-15
IE60870B1 (en) 1994-08-24
IE882366L (en) 1989-02-04
GB2207922B (en) 1991-02-20
FR2621317A1 (fr) 1989-04-07
GB2207922A (en) 1989-02-15

Similar Documents

Publication Publication Date Title
BE1003227A3 (fr) Tripeptides utiles comme immunostimulants de meme que dans la prevention des metastases.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
MY130668A (en) Isothiazole derivatives useful as anticancer agents
TNSN96161A1 (fr) Derives de la quinoleine et de quinazoline nouveaux procede pour leur preparation et formulations pharmaceutiques les contenant.
MA24694A1 (fr) Derives de thienopyrimidine et thienopyridine utiles comme agents anticancereux, et compositions les contenant.
HUT66863A (en) Process for preparation of oxadiazole and tiadiazole derivatives and pharmaceutical compositions containing them
TNSN91070A1 (fr) Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant.
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
IE830479L (en) Carboxyalkyl dipeptides
HU913396D0 (en) Process for the production of azasteroide compounds and medical preparations containing them as active agents
MA27676A1 (fr) 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
NO302414B1 (no) Analogifremgangsmåte for fremstilling av heterocykliske forbindelser
HUP0400732A2 (hu) Gyógyászatilag hatékony uridin-észterek
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26690A1 (fr) COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1,2-a ] PYRAZINE ET PROCEDE POUR LEUR PREPARATION
EP0268281A3 (en) Pyrrolidineamide derivative having anti-prolyl endopeptidase activity, compositions comprising the same, processes for the preparation of the same, and the use of the same for the preparation of a medicament of therapeutic value
CA2071971A1 (fr) Emploi de l'arginine comme immunostimulant
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
IL128562A0 (en) Fatty acid treatment
CA2167040A1 (fr) Nouveaux composes (hetero)cycliques alkyles, leur procede de preparationet les compositions pharmaceutiques qui les contiennent
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
TNSN97143A1 (fr) Derives de trans-piperazine-1-yl-spiro(cyclohexane-1, 1'- isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
EP1419129A4 (fr) Utilisation d'acides gras a chaine ramifiee et derives de ces acides gras pour le traitement de la douleur

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ELLEM INDUSTRIA FARMACEUTICA S.P.A.

Effective date: 19960831